85 related articles for article (PubMed ID: 16637400)
21. Effect of chloroquine, methylene blue and artemether on red cell and hepatic antioxidant defence system in mice infected with Plasmodium yoelii nigeriensis.
Nneji CM; Adaramoye OA; Falade CO; Ademowo OG
Parasitol Res; 2013 Jul; 112(7):2619-25. PubMed ID: 23604568
[TBL] [Abstract][Full Text] [Related]
22. Zinc mediates normalization of hepatic drug metabolizing enzymes in chlorpyrifos-induced toxicity.
Goel A; Dani V; Dhawan DK
Toxicol Lett; 2007 Feb; 169(1):26-33. PubMed ID: 17194553
[TBL] [Abstract][Full Text] [Related]
23. Anti-protozoan activities of Harungana madagascariensis stem bark extract on trichomonads and malaria.
Iwalewa EO; Omisore NO; Adewunmi CO; Gbolade AA; Ademowo OG; Nneji C; Agboola OI; Daniyan OM
J Ethnopharmacol; 2008 May; 117(3):507-11. PubMed ID: 18372133
[TBL] [Abstract][Full Text] [Related]
24. Mitochondrial dehydrogenases in the aerobic respiratory chain of the rodent malaria parasite Plasmodium yoelii yoelii.
Kawahara K; Mogi T; Tanaka TQ; Hata M; Miyoshi H; Kita K
J Biochem; 2009 Feb; 145(2):229-37. PubMed ID: 19060309
[TBL] [Abstract][Full Text] [Related]
25. Effect of Plasmodium yoelii nigeriensis infection on hepatic and splenic glutathione-S-transferase(s) in Swiss albino and db/+ mice: efficacy of mefloquine and menadione in antimalarial chemotherapy.
Ahmad R; Srivastava AK
Parasitology; 2007 Jul; 134(Pt 7):931-8. PubMed ID: 17352848
[TBL] [Abstract][Full Text] [Related]
26. Prophylactic potential of liposomized integral membrane protein of Plasmodium yoelii nigeriensis against blood stage infection in BALB/c mice.
Sharma SK; Gupta C; Dwivedi V; Misra-Bhattacharya S; Mohammad O
Vaccine; 2007 Mar; 25(11):2103-11. PubMed ID: 17241709
[TBL] [Abstract][Full Text] [Related]
27. In vivo antimalarial activity of leaves of Plectranthus amboinicus (lour) spreng on Plasmodium berghei yoelii.
Periyanayagam K; Nirmala Devi K; Suseela L; Uma A; Ismail M
J Commun Dis; 2008 Jun; 40(2):121-5. PubMed ID: 19301696
[TBL] [Abstract][Full Text] [Related]
28. A plant-derived morphinan as a novel lead compound active against malaria liver stages.
Carraz M; Jossang A; Franetich JF; Siau A; Ciceron L; Hannoun L; Sauerwein R; Frappier F; Rasoanaivo P; Snounou G; Mazier D
PLoS Med; 2006 Dec; 3(12):e513. PubMed ID: 17194195
[TBL] [Abstract][Full Text] [Related]
29. Conventional and experimental treatment of cerebral malaria.
Golenser J; McQuillan J; Hee L; Mitchell AJ; Hunt NH
Int J Parasitol; 2006 May; 36(5):583-93. PubMed ID: 16603167
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of beta-arteether and alpha/beta-arteether for treatment of acute Plasmodium falciparum malaria.
Pareek A; Nandy A; Kochar D; Patel KH; Mishra SK; Mathur PC
Am J Trop Med Hyg; 2006 Jul; 75(1):139-42. PubMed ID: 16837720
[TBL] [Abstract][Full Text] [Related]
31. Study on protective immunity against infection of Plasmodium yoelii 17XL in DBA/2 mice.
Zheng W; Liu J; Meng DY; Hu XF; Cao YM
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Feb; 24(1):14-8. PubMed ID: 16866134
[TBL] [Abstract][Full Text] [Related]
32. Potential cerebral malaria therapy: intramuscular arteether and vitamin D co-administration.
Dwivedi H; Singh SK; Chauhan BS; Gunjan S; Tripathi R
Parasitology; 2016 Oct; 143(12):1557-68. PubMed ID: 27440106
[TBL] [Abstract][Full Text] [Related]
33. Changes in the visceral functions of Plasmodium berghei-infected and -uninfected rats following administration of artemether.
Akomolafe RO; Adeoshun IO; Fakunle JB; Iwalewa EO; Ayoka AO; Akanji BO
Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1180-3. PubMed ID: 17184498
[TBL] [Abstract][Full Text] [Related]
34. New adamantane-based spiro 1,2,4-trioxanes orally effective against rodent and simian malaria.
Singh C; Kanchan R; Sharma U; Puri SK
J Med Chem; 2007 Feb; 50(3):521-7. PubMed ID: 17266204
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and structure-activity relationships of 4-pyridones as potential antimalarials.
Yeates CL; Batchelor JF; Capon EC; Cheesman NJ; Fry M; Hudson AT; Pudney M; Trimming H; Woolven J; Bueno JM; Chicharro J; Fernández E; Fiandor JM; Gargallo-Viola D; Gómez de las Heras F; Herreros E; León ML
J Med Chem; 2008 May; 51(9):2845-52. PubMed ID: 18396855
[TBL] [Abstract][Full Text] [Related]
36. Novel bis- and tris-1,2,4-trioxanes: synthesis and antimalarial activity against multidrug-resistant Plasmodium yoelii in Swiss mice.
Singh C; Verma VP; Naikade NK; Singh AS; Hassam M; Puri SK
J Med Chem; 2008 Dec; 51(23):7581-92. PubMed ID: 19006381
[TBL] [Abstract][Full Text] [Related]
37. Neuropathological studies on Plasmodium yoelii nigeriensis-induced malaria in mice.
Sharma MR; Sharma MC; Tripathi LM; Pandey VC; Maitra SC
J Comp Pathol; 1994 Apr; 110(3):313-7. PubMed ID: 8040397
[TBL] [Abstract][Full Text] [Related]
38. Postprandial lymphatic flux and malaria.
Deharo E; Coquelin F; Chabaud A; Landau I
Parasite; 1995 Dec; 2(4):417-8. PubMed ID: 8745741
[TBL] [Abstract][Full Text] [Related]
39. Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes.
Trimnell A; Takagi A; Gupta M; Richie TL; Kappe SH; Wang R
J Immunol; 2009 Nov; 183(9):5870-8. PubMed ID: 19812194
[TBL] [Abstract][Full Text] [Related]
40. Plasmodium yoelii: experimental evidences for the conserved epitopes between mouse and human malaria parasite, Plasmodium falciparum.
Xu L; Pei X; Berzins K; Chaudhuri A
Exp Parasitol; 2007 Jul; 116(3):214-24. PubMed ID: 17336297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
